Literature DB >> 12546121

A high tuberculosis case-fatality rate in a setting of effective tuberculosis control: implications for acceptable treatment success rates.

J F Fielder1, C P Chaulk, M Dalvi, R Gachuhi, G W Comstock, T R Sterling.   

Abstract

Worldwide, the case-fatality rate of smear-positive pulmonary tuberculosis among persons on treatment is 3.8%. We assessed the case-fatality rate among such patients in Baltimore between January 1993 and June 1998. Tuberculosis incidence was < 17/100 000 population, and 99% of patients received directly observed therapy. Of 174 patients, 42 (24%) died on treatment. Patients who died were older (mean age 62 vs. 47 years; P < 0.001) and were more likely to have underlying medical conditions. In multivariate analyses, older age, diabetes mellitus, and renal failure were independently associated with an increased risk of death. With effective control, tuberculosis may become concentrated in older persons with chronic diseases and be associated with high case-fatality rates. In such settings, acceptable treatment success rates may need to be revised.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12546121

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  30 in total

Review 1.  Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.

Authors:  Kelly Hodgson; Jodie Morris; Tahnee Bridson; Brenda Govan; Catherine Rush; Natkunam Ketheesan
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

2.  Residential urban tree canopy is associated with decreased mortality during tuberculosis treatment in California.

Authors:  Robert J Blount; Lisa Pascopella; Pennan Barry; Joseph Zabner; Emma M Stapleton; Jennifer Flood; John Balmes; Payam Nahid; Donald G Catanzaro
Journal:  Sci Total Environ       Date:  2019-11-20       Impact factor: 7.963

3.  Diabetes mellitus and risk of all-cause mortality among patients with tuberculosis in the state of Georgia, 2009-2012.

Authors:  Matthew J Magee; Mary Foote; David M Maggio; Penelope P Howards; K M Venkat Narayan; Henry M Blumberg; Susan M Ray; Russell R Kempker
Journal:  Ann Epidemiol       Date:  2014-02-08       Impact factor: 3.797

Review 4.  In the shadow of academic medical centers: a systematic review of urban health research in Baltimore City.

Authors:  Nadra C Tyus; M Christopher Gibbons; Karen A Robinson; Claire Twose; Bernard Guyer
Journal:  J Community Health       Date:  2010-08

5.  Mortality before or during treatment among tuberculosis patients in North Carolina, 1993-2003.

Authors:  L T Nguyen; C D Hamilton; Q Xia; J E Stout
Journal:  Int J Tuberc Lung Dis       Date:  2011-02       Impact factor: 2.373

Review 6.  Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis? A systematic review.

Authors:  Marit Eika Jørgensen; Daniel Faurholt-Jepsen
Journal:  Curr Diab Rep       Date:  2014-07       Impact factor: 4.810

Review 7.  Tuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary disease.

Authors:  Biswajit Chakrabarti; Peter M A Calverley; Peter D O Davies
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

8.  COPD and the risk of tuberculosis--a population-based cohort study.

Authors:  Malin Inghammar; Anders Ekbom; Gunnar Engström; Bengt Ljungberg; Victoria Romanus; Claes-Göran Löfdahl; Arne Egesten
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

9.  Factors associated with mortality in patients with tuberculosis.

Authors:  David J Horne; Rebecca Hubbard; Masahiro Narita; Alexia Exarchos; David R Park; Christopher H Goss
Journal:  BMC Infect Dis       Date:  2010-08-27       Impact factor: 3.090

10.  A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization.

Authors:  Fiona Young; Julia A Critchley; Lucy K Johnstone; Nigel C Unwin
Journal:  Global Health       Date:  2009-09-14       Impact factor: 4.185

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.